NCT04155424 2024-09-25
A Study of the Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 2/3 Terminated
Alexion Pharmaceuticals, Inc.
Lumos Pharma
Tocagen Inc.
Clovis Oncology, Inc.
Laboratorio Elea Phoenix S.A.